Sounds good. Hopefully a stack with dutasteride will help with hairloss.. or will help at all.June.
Sounds good. Hopefully a stack with dutasteride will help with hairloss.. or will help at all.June.
you say? I have heard that together with the RU it is able to completely or almost completely reverse the processSounds good. Hopefully a stack with dutasteride will help with hairloss.. or will help at all.
Minoxidil is barely helpful at stopping hair loss. If this just is just as effective as minoxidil then why not use minoxidil? When you look at the finasteride and dutasteride studies, hair counts went DOWN for the placebo.Yeah Minoxidil studies had placebo results hella high people should wait till results get fully released
because not everyone responds to minoxidil due to the enzyme not activating in the scalp. this has a different moa to min as it blocks the ar so you'd assume the results would be more long term than min, anyway 11 people dropped out of placebo so you'd assume their hair was getting worse, anyway here is a finasteride study where placebo increasedMinoxidil is barely helpful at stopping hair loss. If this just is just as effective as minoxidil then why not use minoxidil? When you look at the finasteride and dutasteride studies, hair counts went DOWN for the placebo.
It's a tough pill to swallow but kintor is not the answer. Complete failure, as usual
Why are you judging a product based on how the placebo performed?Minoxidil is barely helpful at stopping hair loss. If this just is just as effective as minoxidil then why not use minoxidil? When you look at the finasteride and dutasteride studies, hair counts went DOWN for the placebo.
It's a tough pill to swallow but kintor is not the answer. Complete failure, as usual
because you want a comparison: you want to know to what extent the remedy is helpful in relation to no treatment (placebo). Since we know that hair loss is a b**ch, we assume that the hair loss will progress, i.e. the result with placebo will be worse. here, however, it has increased significantly, which is unusual and of course also makes the end result worse or more unreasonable overall. The success of KX would have been clearer if the placebo group had not had an improvement. Also, it's questionable why they had any improvement: seasonal shedding, continued use of other treatments (have heard from a few at Tressless who were convinced they were in a placebo group and therefore switched to finasteride etc.) or whatever. it remains unclear, I would say.Why are you judging a product based on how the placebo performed?
Yep, I agree with what you wrote. On top of the confounding factors you mentioned, it also looks like quite a few participants in the placebo group actually dropped out of the trial; presumably they noticed their hairloss progressing. Those people dropping out would've raised the average score of the placebo group. But the person I was replying to was saying that Kintor's a "complete failure" because the placebo group improved lmfao.because you want a comparison: you want to know to what extent the remedy is helpful in relation to no treatment (placebo). Since we know that hair loss is a b**ch, we assume that the hair loss will progress, i.e. the result with placebo will be worse. here, however, it has increased significantly, which is unusual and of course also makes the end result worse or more unreasonable overall. The success of KX would have been clearer if the placebo group had not had an improvement. Also, it's questionable why they had any improvement: seasonal shedding, continued use of other treatments (have heard from a few at Tressless who were convinced they were in a placebo group and therefore switched to finasteride etc.) or whatever. it remains unclear, I would say.
I also don't see any point to worrying about the placebo group. What matters is the active therapy group.because you want a comparison: you want to know to what extent the remedy is helpful in relation to no treatment (placebo). Since we know that hair loss is a b**ch, we assume that the hair loss will progress, i.e. the result with placebo will be worse. here, however, it has increased significantly, which is unusual and of course also makes the end result worse or more unreasonable overall. The success of KX would have been clearer if the placebo group had not had an improvement. Also, it's questionable why they had any improvement: seasonal shedding, continued use of other treatments (have heard from a few at Tressless who were convinced they were in a placebo group and therefore switched to finasteride etc.) or whatever. it remains unclear, I would say.
No one knows yet. AR upregulation might be a real thing and Kintor didn't want to risk it with 12 months.If Phase 3 duration is also 6 months, then how we know if efficacy will go down after that mark?
Risk what? If customers find out that it's efficacy goes heavily down after 6 months no one will buy it anymore, what's the point of releasing it in the first place?No one knows yet. AR upregulation might be a real thing and Kintor didn't want to risk it with 12 months.
To get the sales in the first year, before customers find out?Risk what? If customers find out that it's efficacy goes heavily down after 6 months no one will buy it anymore, what's the point of releasing it in the first place?
A year of sales wouldn’t cover development costs… not even close.To get the sales in the first year, before customers find out?
I've seen drugs get approved that will never recoup their development costs lolA year of sales wouldn’t cover development costs… not even close.
I don't understand why you would progress to phase 3 and the costs involved in that if you're aware the phase 2 results are lackingBad news guys. Kintor has delayed the publication of phase II results again to September 2022.
Unfortunately, really looks like an other scam.